
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co Inc. demonstrates a strong outlook driven by robust demand in the behavioral health sector, which has resulted in impressive organic growth through bed expansions and new developments. The company is positioned well for mergers and acquisitions due to strong capitalization, and it anticipates operational improvements as organic earnings growth is forecasted to rise. Additionally, a significant increase in net PLGL liability signals the company's proactive management of future claims amidst an environment of increasing claim frequency and associated costs.
Bears say
Acadia Healthcare Co Inc has faced a significant downward revision in its EBITDA guidance for 2025 by approximately 13.4%, reflecting a reduction of $94 million, primarily due to underestimating higher-than-expected PLGL expenses. Additionally, projections for 2026 anticipate continued elevated PLGL expenses between $100-110 million, which remain substantially above historical norms and are likely to pressure margins over the long term. This persistent increase in expenses, coupled with projected volume softness, leads to concerns that FY26 EBITDA may fall around 5% below current estimates, indicating a potential contraction in the enterprise multiple to levels significantly below historical averages for acute care hospitals.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares